All Stories

  1. Ritmos circadianos e o futuro da medicina de precisão
  2. Widespread annual rhythms in pediatric emergencies
  3. Upper Airway Stimulation for Children and Adolescents with Down Syndrome: Long‐Term Follow‐Up
  4. Trajectory of Sleep, Depression, and Quality of Life in Pediatric HSCT Recipients
  5. Does ChatGPT Answer Otolaryngology Questions Accurately?
  6. Circadian blood pressure dysregulation in children with obstructive sleep apnea
  7. Current Considerations in the Diagnosis and Treatment of Circadian Rhythm Sleep-Wake Disorders in Children
  8. Murine Pro‐Inflammatory Responses to Acute and Sustained Intermittent Hypoxia: Implications for Obstructive Sleep Apnea Research
  9. Obstructive sleep apnea in a mouse model is associated with tissue-specific transcriptomic changes in circadian rhythmicity and mean 24-hour gene expression
  10. Diurnal regulation of metabolism by Gs-alpha in hypothalamic QPLOT neurons
  11. Daytime-restricted parenteral feeding is associated with earlier oral intake in children following stem cell transplant
  12. Integration of genome-scale data identifies candidate sleep regulators
  13. A Word of Caution: Adenotonsillectomy May Help Reduce Central Apneas, but It Is Not a Treatment for Central Sleep Apnea
  14. Epigenetics of obstructive sleep apnea syndrome: a systematic review
  15. Early Atherosclerotic Inflammatory Pathways in Children with Obstructive Sleep Apnea
  16. Improving outcomes of hypoglossal nerve stimulation therapy: current practice, future directions, and research gaps. Proceedings of the 2019 International Sleep Surgery Society Research Forum
  17. Intermittent Hypoxia Alters the Circadian Expression of Clock Genes in Mouse Brain and Liver
  18. Circadian Biology in Obstructive Sleep Apnea
  19. HPV Strain Predicts Severity of Juvenile-Onset Recurrent Respiratory Papillomatosis with Implications for Disease Screening
  20. Elevation of CD40/CD40L Inflammatory Pathway Molecules in Carotid Plaques from Moderate-and-Severe Obstructive Sleep Apnea Patients
  21. Machine learning approaches to identify sleep genes
  22. Short-term exposure to intermittent hypoxia leads to changes in gene expression seen in chronic pulmonary disease
  23. Systemic Bevacizumab for Treatment of Respiratory Papillomatosis: International Consensus Statement
  24. Patient-Derived Organotypic Epithelial Rafts Model Phenotypes in Juvenile-Onset Recurrent Respiratory Papillomatosis
  25. Sleep Architecture in Children With Down Syndrome With and Without Obstructive Sleep Apnea
  26. Polysomnographic Outcomes After Observation for Mild Obstructive Sleep Apnea in Children Younger Than 3 Years
  27. Demographic and Clinical Characteristics Associated With Adherence to Guideline-Based Polysomnography in Children With Down Syndrome
  28. A population-based gene expression signature of molecular clock phase from a single epidermal sample
  29. Effectiveness of pediatric drug-induced sleep endoscopy for REM-predominant obstructive sleep apnea
  30. Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells
  31. TLRs and RAGE are elevated in carotid plaques from patients with moderate-to-severe obstructive sleep apnea syndrome
  32. Vagus Nerve Stimulator–Associated Sleep Disordered Breathing: Identification, Treatment, and Outcomes in a Pediatric Patient
  33. Hypoxia induces a time- and tissue-specific response that elicits intertissue circadian clock misalignment
  34. When Should You Take Your Medicines?
  35. Outcomes in children with down syndrome and mild obstructive sleep apnea treated non‐surgically
  36. A large-scale study reveals 24-h operational rhythms in hospital treatment
  37. Dosing time matters
  38. Sleep and Circadian Medicine
  39. OSA and Cardiovascular Risk in Pediatrics
  40. Effects of Medical Therapy on Mild Obstructive Sleep Apnea in Adult Patients
  41. Adherence to Guidelines for Screening Polysomnography in Children with Down Syndrome
  42. Population-level rhythms in human skin with implications for circadian medicine
  43. A database of tissue-specific rhythmically expressed human genes has potential applications in circadian medicine
  44. The role of disruption of the circadian clock in obstructive sleep apnea
  45. Preliminary Assessment of Dynamic Voice CT in Post–Airway Reconstruction Patients
  46. Sleep Disorders and Their Management in Children With Ehlers-Danlos Syndrome Referred to Sleep Clinics
  47. Admission Criteria for Children With Obstructive Sleep Apnea After Adenotonsillectomy: Considerations for Cost
  48. Polysomnographic Oxygen Saturation Findings for Preteen Children versus Adolescents
  49. Outcomes of Drug-Induced Sleep Endoscopy–Directed Surgery for Pediatric Obstructive Sleep Apnea
  50. Short- versus Long-term Stenting in Children with Subglottic Stenosis Undergoing Laryngotracheal Reconstruction
  51. Polysomnography in Pediatric Otolaryngology: If Not Obstructive Sleep Apnea, What Is It?
  52. 0560 EFFECTS OF MEDICAL THERAPY ON MILD OBSTRUCTIVE SLEEP APNEA IN ADULT PATIENTS
  53. 0929 THE MANAGEMENT OF SLEEP DISORDERS IN CHILDREN WITH EHLERS-DANLOS SYNDROME
  54. 0928 CLINICAL PRESENTATION OF SLEEP DISORDERS IN CHILDREN WITH EHLERS-DANLOS SYNDROME
  55. Upper lateral cartilage composite flap for closure of complicated septal perforations
  56. Complete surgical resection and short-term survival in acute invasive fungal rhinosinusitis
  57. Inflammatory Milieu and Cardiovascular Homeostasis in Children With Obstructive Sleep Apnea
  58. Temporal trends in inpatient pediatric sleep apnea surgery: 1993-2010
  59. Anthropometric and Dental Measurements in Children with Obstructive Sleep Apnea
  60. Improvement in hearing loss over time in Cornelia de Lange syndrome
  61. Screening for Pediatric Obstructive Sleep Apnea before Ambulatory Surgery
  62. Surgical Management of OSA in Adults
  63. Intraoperative Laser-Assisted Indocyanine Green Imaging for Objective Measurement of the Vascular Delay Technique in Locoregional Head and Neck Flaps
  64. Human papillomavirus status of head and neck cancer as determined in cytologic specimens using the hybrid-capture 2 assay
  65. Financial incentive of home continuous positive airway pressure machine use in the inpatient hospital setting
  66. Traumatic gunshot wound to the larynx with subsequent aspiration of the bullet
  67. Whose experience is measured?: A pilot study of patient satisfaction demographics in pediatric otolaryngology
  68. Chronic Rhinosinusitis in Children
  69. A pilot staging system to predict persistent obstructive sleep apnea in children following adenotonsillectomy
  70. Human Papillomavirus-related Carcinomas of the Sinonasal Tract
  71. Weight Gain after Adenotonsillectomy Is More Common in Young Children
  72. Epidemiology of Chronic Rhinosinusitis in Children
  73. Weight Gain Post-tonsillectomy More Common in Young Children
  74. Unverifiable Publications in Otolaryngology Residency Applications
  75. The prevalence of sleepiness and the risk of sleep-disordered breathing in children with positive allergy test
  76. Racial/ethnic and socioeconomic disparities in the diagnosis and treatment of sleep-disordered breathing in children
  77. Racial/Ethnic and socioeconomic disparities in the prevalence and treatment of otitis media in children in the United States
  78. Complete traumatic laryngotracheal disruption—A case report and review
  79. α2,3-Sialyltransferase-IV is essential for L-selectin ligand function in inflammation
  80. Leukocyte phosphoinositide-3 kinase γ is required for chemokine-induced, sustained adhesion under flow in vivo
  81. Critical role of endothelial CXCR2 in LPS-induced neutrophil migration into the lung
  82. Induction of LFA-1-Dependent Neutrophil Rolling on ICAM-1 by Engagement of E-Selectin
  83. GRO family chemokines are specialized for monocyte arrest from flow
  84. Critical Role of Macrophage 12/15-Lipoxygenase for Atherosclerosis in Apolipoprotein E–Deficient Mice
  85. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E
  86. Enhanced protection from renal ischemia: Reperfusion injury with A2A-adenosine receptor activation and PDE 4 inhibition
  87. Enhanced protection from renal ischemia: Reperfusion injury with A2A-adenosine receptor activation and PDE 4 inhibition
  88. Medium-Chain Acyl Coenzyme A Dehydrogenase Deficiency